Think Therapeutics, Inc.

Newton, MA Doing business as Think Therapeutics Inc.

UEI
G18KSS1LXQ71
CAGE
8T9J6
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
94 Park Ave, Newton, MA 02458, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Think Therapeutics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Brilliant epitopes for improved cancer vaccines - project summary we propose to advance next-generation cancer… Grant · R43CA302015 National Cancer Institute $811,198
Machine learning optimized autoimmune therapeutics with a focus on type 1 diabetes - project summary we propose to… Grant · R43AI177185 National Institute of Allergy and Infectious Diseases $613,000

SBA capabilities narrative

From the vendor's SBA profile

Computational design of therapeutics and vaccines, therapeutic and vaccine manufacturing

Quick answers

What is Think Therapeutics, Inc.'s UEI?

Think Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is G18KSS1LXQ71.

What is Think Therapeutics, Inc.'s CAGE code?

Think Therapeutics, Inc.'s CAGE code is 8T9J6.

What is Think Therapeutics, Inc.'s primary NAICS code?

Think Therapeutics, Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Where is Think Therapeutics, Inc. located?

Think Therapeutics, Inc.'s physical address in SAM.gov is 94 Park Ave, Newton, MA 02458, USA.

Is Think Therapeutics, Inc. registered in SAM.gov?

Yes. Think Therapeutics, Inc.'s SAM.gov registration is active through March 9, 2027.

What is Think Therapeutics, Inc.'s most recent federal award?

Think Therapeutics, Inc.'s most recent federal grant award is Brilliant epitopes for improved cancer vaccines - project summary we propose to advance next-generation cancer… (R43CA302015), from National Cancer Institute, on September 8, 2025.

On GovTribe

See Think Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login